Role of anesthetic agents on cardiac and immune systems

Shock

Volumn 36, Issue 6, 2011, Pages 532-541

  Yu, Huang Ping ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

anesthesia; Heart; immune; inhalational agents; intravenous anesthetics

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; DESFLURANE; GUANINE NUCLEOTIDE BINDING PROTEIN; HALOTHANE; ISOFLURANE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SEVOFLURANE;

ANTIINFLAMMATORY ACTIVITY; CALCIUM HOMEOSTASIS; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; IMMUNE RESPONSE; INTRACELLULAR SIGNALING; NATURAL KILLER CELL; NONHUMAN; REPERFUSION INJURY; REVIEW;

ANESTHETICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; HEART; HUMANS; IMMUNE SYSTEM;

EID: 81755180526     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182357054     Document Type: Review

References (137)

1. Lamberts RR, Onderwater G, Hamdani N, Vreden MJ, Steenhuisen J, Eringa EC, Loer SA, Stienen GJ, Bouwman RA: Reactive oxygen speciesYinduced stimulation of 5¶ AMPYactivated protein kinase mediates sevoflurane-induced cardioprotection. Circulation 120(Suppl):S10YS15, 2009.
2. Huang Z, Zhong X, Irwin MG, Ji S, Wong GT, Liu Y, Xia ZY, Finegan BA, Xia Z: Synergy of isoflurane preconditioning and propofol postconditioning reduces myocardial reperfusion injury in patients. Clin Sci (Lond) 121:57-69, 2011.
3. Frädorf J, Huhn R, Weber NC, Ebel D, Wingert N, Preckel B, Toma O, Schlack W, Hollmann MW: Sevoflurane-induced preconditioning: impact of protocol and aprotinin administration on infarct size and endothelial nitricoxide synthase phosphorylation in the rat heart in vivo. Anesthesiology 113: 1289-1298, 2010.
4. Hu ZY, Liu J: Mechanism of cardiac preconditioning with volatile anaesthetics. Anaesth Intensive Care 37:532-538, 2009.
5. Reim D, Westenfelder K, Kaiser-Moore S, Schlautkotter S, Holzmann B, Weighardt H: Role of T cells for cytokine production and outcome in a model of acute septic peritonitis. Shock 31:245-250, 2009.
6. Brahmamdam P, Watanabe E, Unsinger J, Chang KC, Schierding W, Hoekzema AS, Zhou TT, McDonough JS, Holemon H, Heidel JD, et al.: Targeted delivery of siRNA to cell death proteins in sepsis. Shock 32: 131-139, 2009.
7. Adrie C, Monchi M, Fulgencio JP, Cottias P, Haouache H, Alvarez-Gonzalvez A, Guerrini P, Cavaillon JM, Adib-Conquy M: Immune status and apoptosis activation during brain death. Shock 33:353-362, 2010.
8. Lee CJ, Tai YT, Lin YL, Chen RM: Molecular mechanisms of propofolinvolved suppression of no biosynthesis and inducible iNOS gene expression in LPS-stimulated macrophage-like raw 264.7 cells. Shock 33:93-100, 2010.
9. Marik PE: Propofol: an immunomodulating agent. Pharmacotherapy 25: 28S-33S, 2005. (Pubitemid 40604876)
10. Chang HC, Lin KH, Tai YT, Chen JT, Chen RM: Lipoteichoic acidYinduced TNF-! and IL-6 gene expressions and oxidative stress production in macrophages are suppressed by ketamine through downregulating Toll-like receptor 2Ymediated activation of ERK1/2 and NF.B. Shock 33:485-492, 2010.
11. Tsutsumi YM, Kawaraguchi Y, Horikawa YT, Niesman IR, Kidd MW, Chin-Lee B, Head BP, Patel PM, Roth DM, Patel HH: Role of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection. Anesthesiology 112:1136-1145, 2010.
12. Hieber S, Huhn R, Hollmann MW, Weber NC, Preckel B: Hypoxia-inducible factor 1 and related gene products in anaesthetic-induced preconditioning. Eur J Anaesthesiol 26:201-206, 2009.
13. Raphael J, Zuo Z, Abedat S, Beeri R, Gozal Y: Isoflurane preconditioning decreases myocardial infarction in rabbits via up-regulation of hypoxia inducible factor 1 that is mediated by mammalian target of rapamycin. Anesthesiology 108:415-425, 2008. (Pubitemid 351304235)
14. Bouwman RA, Vreden MJ, Hamdani N, Wassenaar LE, Smeding L, Loer SA, Stienen GJ, Lamberts RR: Effect of bupivacaine on sevoflurane-induced preconditioning in isolated rat hearts. Eur J Pharmacol 647:132-138, 2010.
15. Konia MR, Schaefer S, Liu H: Nuclear factor-.B inhibition provides additional protection against ischemia/reperfusion injury in delayed sevoflurane preconditioning. Eur J Anaesthesiol 26:496-503, 2009.
16. Jin C, Sonoda S, Fan L, Watanabe M, Kugimiya T, Okada T: Sevoflurane and nitrous oxide exert cardioprotective effects against hypoxia-reoxygenation injury in isolated rat heart. J Physiol Sci 59:123-129, 2009.
17. Yu HP, Shimizu T, Choudhry MA, Hsieh YC, Suzuki T, Bland KI, Chaudry IH: Mechanism of cardioprotection following trauma-hemorrhagic shock by a selective estrogen receptor-beta agonist: up-regulation of cardiac heat shock factor-1 and heat shock proteins. J Mol Cell Cardiol 40:185-194, 2006. (Pubitemid 43012129)
18. Zingarelli B, Hake PW, Mangeshkar P, O-Connor M, Burroughs TJ, Piraino G, Denenberg A, Wong HR: Diverse cardioprotective signaling mechanisms of peroxisome proliferators-activated receptor-gamma ligands, 15-deoxy-Delta12,14- prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt. Shock 28:554-563, 2007. (Pubitemid 350287432)
19. Pagel PS: Induction of heat shock protein 70 and preconditioning by sevoflurane: a potent protective interaction against myocardial ischemiareperfusion injury. Anesth Analg 107:742-745, 2008.
20. Lotz C, Fisslthaler B, Redel A, Smul TM, Stumpner J, Pociej J, Roewer N, Fleming I, Kehl F, Lange M: Activation of adenosine-monophosphateY activated protein kinase abolishes desflurane-induced preconditioning against myocardial infarction in vivo. J Cardiothorac Vasc Anesth 25:66-71, 2011.
21. Kevin LG, Novalija E: Anesthetic preconditioning decreases arrhythmias and improves regional conduction in isolated hearts. J Cardiothorac Vasc Anesth 22:217-224, 2008. (Pubitemid 351423672)
22. Lucchinetti E, Jamnicki M, Fischer G, Zaugg M: Preconditioning by isoflurane retains its protection against ischemia-reperfusion injury in postinfarct remodeled rat hearts. Anesth Analg 106:17-23, 2008.
23. Meco M, Cirri S, Gallazzi C, Magnani G, Cosseta D: Desflurane preconditioning in coronary artery bypass graft surgery: a double-blinded, randomized and placebo-controlled study. Eur J Cardiothorac Surg 32:319-325, 2007. (Pubitemid 47021455)
24. Allard MF, Flint JD, English JC, Henning SL, Salamanca MC, Kamimura CT, English DR: Calcium overload during reperfusion is accelerated in isolated hypertrophied rat hearts. J Mol Cell Cardiol 26:1551-1563, 1995.
25. An J, Bosnjak ZJ, Jiang MT: Myocardial protection by isoflurane preconditioning preserves Ca2+ cycling proteins independent of sarcolemmal and mitochondrial KATP channels. Anesth Analg 105:1207-1213, 2007. (Pubitemid 350303917)
26. Dworschak M, Breukelmann D, Hannon JD: The effect of isoflurane during oxygenation on the sarcoplasmic reticulum and cellular injury in isolated ventricular myocytes. Life Sci 78:888-893, 2006. (Pubitemid 43082314)
27. Lorts A, Burroughs T, Shanley TP: Elucidating the role of reversible protein phosphorylation in sepsis-induced myocardial dysfunction. Shock 32:49-54, 2009.
28. Hannon JD, Cody MJ, Sun DX, Housmans PR: Effects of isoflurane and sevoflurane on intracellular calcium and contractility in pressure-overload hypertrophy. Anesthesiology 101:675-686, 2004. (Pubitemid 39121647)
29. Housmans PR, Wanet LA, Carton EG, Bartunek AE: Effects of halothane and isoflurane on the intracellular Ca2+ transient in ferret cardiac muscle. Anesthesiology 93:189-201, 2000. (Pubitemid 30436694)
30. Bartunek AE, Housmans PR: Effects of sevoflurane on the intracellular Ca2+ transient in ferret cardiac muscle. Anesthesiology 93:1500-1508, 2000.
31. Tampo A, Hogan CS, Sedlic F, Bosnjak ZJ, Kwok WM: Accelerated inactivation of cardiac L-type calcium channels triggered by anaesthetic-induced preconditioning. Br J Pharmacol 156:432-443, 2009.
32. Liu H, Wang L, Eaton M, Schaefer S: Sevoflurane preconditioning limits intracellular/mitochondrial Ca2+ in ischemic newborn myocardium. Anesth Analg 101:349-355, 2005. (Pubitemid 41045211)
33. Kokita N, Hara A, Abiko Y, Arakawa J, Hasizume H, Namiki A: Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts. Anesth Analg 86:256-258, 1998.
34. Nakae Y, Fujita S, Namiki A: Propofol inhibits Ca2+ transients but not contraction in intact beating guinea-pig hearts. Anesth Analg 90:1286-1292, 2000. (Pubitemid 30351325)
35. O'Brien A, Stidwill RP, Clapp LH, Singer M: Variable effects of inhibiting iNOS and closing the vascular ATP-sensitive potassium channel (via its poreforming and sulfonylurea receptor subunits) in endotoxic shock. Shock 31: 535-541, 2009.
36. Nakagawa M, Hori S, Adachi T, Miyazaki K, Inoue S, Suzuki M, Mori H, Nakazawa H, Aikawa N, Ogawa S: Adenosine triphosphateYsensitive potassium channels prevents extension of myocardial ischemia to subepicardium during hemorrhagic shock. Shock 30:178-183, 2008.
37. Velly LJ, Canas PT, Guillet BA, Labrande CN, Masmejean FM, Nieoullon AL, Gouin FM, Bruder NJ, Pisano PS: Early anesthetic preconditioning in mixed cortical neuronal-glial cell cultures subjected to oxygen-glucose deprivation: the role of adenosine triphosphate dependent potassium channels and reactive oxygen species in sevoflurane-induced neuroprotection. Anesth Analg 108:955-963, 2009.
38. Toyoda Y, Friehs I, Parker RA, Levitsky S, McCully JD: Differential role of sarcolemmal and mitochondrial K(ATP) channels in adenosine-enhanced ischemic preconditioning. Am J Physiol Heart Circ Physiol 279:H2694-H2703, 2000. (Pubitemid 32005857)
39. Bienengraeber M, Warltier DC, Bosnjak ZJ, Stadnicka A: Mechanism of cardiac sarcolemmal adenosine triphosphateYsensitive potassium channel activation by isoflurane in a heterologous expression system. Anesthesiology 105:534-540, 2006. (Pubitemid 44310436)
40. Obal D, Dettwiler S, Favoccia C, Scharbatke H, Preckel B, Schlack W: The influence of mitochondrial KATP-channels in the cardioprotection of preconditioning and postconditioning by sevoflurane in the rat in vivo. Anesth Analg 101:1252-1260, 2005. (Pubitemid 41531854)
41. Jiang MT, Nakae Y, Ljubkovic M, Kwok WM, Stowe DF, Bosnjak ZJ: Isoflurane activates human cardiac mitochondrial adenosine triphosphateY sensitive K+ channels reconstituted in lipid bilayers. Anesth Analg 105: 926-932, 2007. (Pubitemid 47479302)
42. Chen CH, Liu K, Chan JY: Anesthetic preconditioning confers acute cardioprotection via up-regulation of manganese superoxide dismutase and preservation of mitochondrial respiratory enzyme activity. Shock 29:300-308, 2008.
43. Hanouz JL, Yvon A, Massetti M, Lepage O, Babatasi G, Khayat A, Bricard H, Gerard JL: Mechanisms of desflurane-induced preconditioning in isolated human right atria in vitro. Anesthesiology 97:33-41, 2002. (Pubitemid 34733919)
44. Toller WG, Gross ER, Kersten JR, Pagel PS, Gross GJ, Warltier DC: Sacrolemmal and mitochondrial adenosine triphosphateYdependent potassium channels: mechanism of desflurane-induced cardioprotection. Anesthesiology 92:1731-1739, 2000. (Pubitemid 30412494)
45. Toda N, Toda H, Hatano Y: Nitric oxide: involvement in the effects of anesthetic agents. Anesthesiology 107:822-842, 2007. (Pubitemid 351325975)
46. Amour J, Brzezinska AK, Weihrauch D, Billstrom AR, Zielonka J, Krolikowski JG, Bienengraeber MW, Warltier DC, Pratt PF Jr, Kersten JR: Role of heat shock protein 90 and endothelial nitric oxide synthase during early anesthetic and ischemic preconditioning. Anesthesiology 110:317-325, 2009.
47. Smul TM, Redel A, Stumpner J, Lange M, Lotz C, Roewer N, Kehl F: Time course of desflurane-induced preconditioning in rabbits. J Cardiothorac Vasc Anesth 24:91-98, 2010.
48. Lotz C, Lange M, Redel A, Stumpner J, Schmidt J, Tischer-Zeitz T, Roewer N, Kehl F: Peroxisome-proliferatorYactivated receptor + mediates the second window of anaesthetic-induced preconditioning. Exp Physiol 96:317-324, 2011.
49. Smul TM, Lange M, Redel A, Stumpner J, Lotz CA, Roewer N, Kehl F: Desflurane-induced cardioprotection against ischemia-reperfusion injury depends on timing. J Cardiothorac Vasc Anesth 23:600-606, 2009.
50. Chi OZ, Hunter C, Liu X, Weiss HR: The effects of isoflurane pretreatment on cerebral blood flow, capillary permeability, and oxygen consumption in focal cerebral ischemia in rats. Anesth Analg 110:1412-1418, 2010.
51. Chen CH, Chuang JH, Liu K, Chan JY: Nitric oxide triggers delayed anesthetic preconditioningYinduced cardiac protection via activation of nuclear factorkappaB and upregulation of inducible nitric oxide. Shock 30:241-249, 2008.
52. Feng J, Zuo Z: Isoflurane preconditioning increases endothelial cell tolerance to in-vitro stimulated ischaemia. J Pharm Pharmacol 63:106-110, 2011.
53. Pravdic D, Sedlic F, Mio Y, Vladic N, Bienengraeber M, Bosnjak ZJ: Anesthetic-induced preconditioning delays opening of mitochondrial permeability transition pore via protein kinase C-epsilonYmediated pathway. Anesthesiology 111:267-274, 2009.
54. Okusa C, Miyamae M, Sugioka S, Kaneda K, Inamura Y, Onishi A, Domae N, Kotani J, Figueredo VM: Acute memory phase of sevoflurane preconditioning is associated with sustained translocation of protein kinase C-alpha and epsilon, but not delta, in isolated guinea pig hearts. Eur J Anaesthesiol 26:582-588, 2009.
55. Wang S, Dai ZG, Dong XW, Guo SX, Liu Y, Wang ZP, Zeng YM: Duplicate preconditioning with sevoflurane in vitro improves neuroprotection in rat brain via activating the extracellular signalYregulated protein kinase. Neurosci Bull 26:437-444, 2010.
56. Ding Q, Wang Q, Deng J, Gu Q, Hu S, Li Y, Su B, Zeng Y, Xiong L: Sevoflurane preconditioning induces rapid ischemic tolerance against spinal cord ischemia/reperfusion through activation of extracellular signalYregulated kinase in rabbits. Anesth Analg 109:1263-1272, 2009.
57. Roesslein M, Frick M, Auwaerter V, Humar M, Goebel U, Schwer C, Geiger KK, Pahl HL, Pannen BH, Loop T: Sevoflurane-mediated activation of p38-mitogen activated stress kinase is independent of apoptosis in Jurkat T-cells. Anesth Analg 106:1150-1160, 2008. (Pubitemid 351450540)
58. Yan J, Qian Z, Sheng L, Zhao B, Yang L, Ji H, Han X, Zhang R: Effect of crocetin on blood pressure restoration and synthesis of inflammatory mediators in heart after hemorrhagic in anesthetized rats. Shock 33:83-87, 2010.
59. Sepac A, Sedlic F, Si-Tayeb K, Lough J, Duncan SA, Bienengraeber M, Park F, Kim J, Bosnjak ZJ: Isoflurane preconditioning elicits competent endogenous mechanisms of protection from oxidative stress in cardiomyocytes derived from human embryonic stem cells. Anesthesiology 113:906-916, 2010.
60. Sedlic F, Pravdic D, Hirata N, Mio Y, Sepac A, Camara AK, Wakatsuki T, Bosnjak ZJ, Bienengraeber M: Monitoring mitochondrial electron fluxes using NAD(P)H-flavoprotein fluorometry reveals complex action of isoflurane on cardiomyocytes. Biochim Biophys Acta 1797:1749-1758, 2010.
61. Zhang Y, Dong Y, Wu X, Lu Y, Xu Z, Knapp A, Yue Y, Xu T, Xie Z: The mitochondrial pathway of anesthetic isoflurane-induced apoptosis. J Biol Chem 285:4025-4037, 2010.
62. Sedlic F, Pravdic D, Ljubkovic M, Marinovic J, Stadnicka A, Bosnjak ZJ: Differences in production of reactive oxygen species and mitochondrial uncoupling as events in the preconditioning signaling cascade between desflurane and sevoflurane. Anesth Analg 109:405-411, 2009.
63. Hanouz JL, Zhu L, Lemoine S, Durand C, Lepage O, Massetti M, Khayat A, Plaud B, Gérard JL: Reactive oxygen species mediate sevoflurane-and desflurane-induced preconditioning in isolated human right atria in vitro. Anesth Analg 105:1534-1539, 2007. (Pubitemid 350190540)
64. Yang Q, Dong H, Deng J, Wang Q, Ye R, Li X, Hu S, Dong H, Xiong L: Sevoflurane preconditioning induces neuroprotection through reactive oxygen speciesYmediated up-regulation of antioxidant enzymes in rats. Anesth Analg 112:931-937, 2011.
65. Yao YT, Li LH, Chen L, Wang WP, Li LB, Gao CQ: Sevoflurane postconditioning protects isolated rat hearts against ischemia-reperfusion injury: the role of radical oxygen species, extracellular signalYrelated kinases 1/2 and mitochondrial permeability transition pore. Mol Biol Rep 37:2439-2446, 2010.
66. Toller WG, Kersten JR, Gross ER, Pagel PS, Warltier DC: Isoflurane preconditions myocardium against infarction via activation of inhibitory guanine nucleotide binding proteins. Anesthesiology 92:1400-1407, 2000. (Pubitemid 30257202)
67. Pentyala SN, Sung K, Chowdhury A, Rebecchi MJ: Volatile anesthetics modulate the binding of guanine nucleotides to the alpha subunits of heterotrimeric GTP binding proteins. Eur J Pharmacol 384:213-222, 1999. (Pubitemid 30006958)
68. Enoh VT, Lin SH, Lin CY, Toliver-Kinsky T, Murphey ED, Varma TK, Sherwood ER:Mice depleted of alphabeta but not gammadelta T cells are resistant to mortality caused by cecal ligation and puncture. Shock 27:507-519, 2007. (Pubitemid 46626078)
69. de Kruif MD, Lemaire LC, Giebelen IA, Groot AP, Pater JM, van den Pangaart PS, Elliott PJ, van der Poll T: Effects of prednisolone on the systemic release of mediators of cell-mediated cytotoxicity during human endotoxemia. Shock 29:458-461, 2008. (Pubitemid 351416798)
70. Sherwood ER, Enoh VT, Murphey ED, Lin CY: Mice depleted of CD8+ T and NK cells are resistant to injury caused by cecal ligation and puncture. Lab Invest 84:1655-1665, 2004. (Pubitemid 39600572)
71. Bar-Yosef S, Melamed R, Page GG, Shakhar G, Shakhar K, Ben-Eliyahu S: Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 94:1066-1073, 2001. (Pubitemid 32506136)
72. Kutza J, Gratz I, Afshar M, Murasko DM: The effects of general anesthesia and surgery on basal and interferon stimulated natural killer cell activity of humans. Anesth Analg 85:918-923, 1997. (Pubitemid 27418904)
73. Wada H, Seki S, Takahashi T, Kawarabayashi N, Higuchi H, Habu Y, Sugahara S, Kazama T: Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance. Anesthesiology 106: 499-506, 2007. (Pubitemid 46662215)
74. Tilley SL, Coffman TM, Koller BH: Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes, J Clin Invest 108:15-23, 2001. (Pubitemid 32634916)
75. Chen YT, Tsai SH, Sheu SY, Tsai LH: Ghrelin improves LPS-induced gastrointestinal motility disturbances: roles of NO and prostaglandin E2. Shock 33:205-212, 2010.
76. Inada T, Kubo K, Shingu K: Promotion of interferon-gamma production by natural killer cells via suppression of murine peritoneal macrophage prostaglandin E2 production using intravenous anesthetic propofol. Int Immunopharmacol 10:1200-1208, 2010.
77. Kalimeris K, Christodoulaki K, Karakitsos P, Batistatou A, Lekka M, Bai M, Kitsiouli E, Nakos G, Kostopanagiotou G: Influence of propofol and volatile anaesthetics on the inflammatory response in the ventilated lung. Acta Anaesthesiol Scand 55:740-748, 2011.
78. Li QF, Zhu YS, Jiang H, Xu H, Sun Y: Hemeoxygenase-1 mediates the antiinflammatory effect of isoflurane preconditioning in LPS-stimulated macrophages. Acta Pharmacol Sin 30:228-234, 2009.
79. Xu X, Feng J, Zuo Z: Isoflurane preconditioning reduces the rat NR8383 macrophage injury induced by lipopolysaccharide and interferon gamma. Anesthesiology 108:643-650, 2008. (Pubitemid 351440585)
80. Colucci D, Harvey G, Gayol MC, Elena G, Puig N: Halothane anesthesia in mice: effect on the phagocytic activity and respiratory burst of peritoneal macrophages. Neuroimmunomodulation 18:11-18, 2011.
81. Annecke T, Kubitz JC, Langer K, Hilberath JM, Kahr S, Krombach F, Bittmann I, Rehm M, Kemming GI, Conzen PF: Lung injury following thoracic aortic occlusion: comparison of sevoflurane and propofol anaesthesia. Acta Anaesthesiol Scand 52:977-986, 2008. (Pubitemid 351951768)
82. Lee HT, Kim M, Kim M, Kim N, Billings FT 4th, D'Agati VD, Emala CW Sr: Isoflurane protects against renal ischemia and reperfusion injury and modulates leukocyte infiltration in mice. Am J Physiol Renal Physiol 293: F713-F722, 2007. (Pubitemid 47403341)
83. Hamra JG, Yaksh TL: Halothane inhibits T cell proliferation and interleukin-2 receptor expression in rats. Immunopharmacol Immunotoxicol 18:323-336, 1996. (Pubitemid 26198292)
84. Mitsuhata H, Shimizu R, Yokoyama MM: Suppressive effects of volatile anesthetics on cytokine release in human peripheral blood mononuclear cells. Int J Immunopharmacol 17:529-534, 1995.
85. Beilin B, Rusabrov Y, Shapira Y, Roytblat L, Greemberg L, Yardeni IZ, Bessler H: Low-dose ketamine affects immune responses in humans during the early postoperative period. Br J Anaesth 99:522-527, 2007. (Pubitemid 47412495)
86. Schneemilch CE, Hachenberg T, Ansorge S, Ittenson A, Bank U: Effects of different anaesthetic agents on immune cells function in vitro. Eur J Anaesthesiol 22:616-623, 2005. (Pubitemid 41097865)
87. Ren XF, Li WZ, Meng FY, Lin CF: Differential effect of propofol and isoflurane on the activation of T-helper cells in lung cancer patients. Anaesthesia 65:478-482, 2010.
88. Li CH, Lee RP, Lin YL, Lin CS, Hsu BG, Tseng FJ, Chen YC, Liao KW, Yang FL: The treatment of propofol induced the TGF-"1 expression in human endothelial cells to suppress endocytosis activities of monocytes. Cytokine 52: 203-209, 2010.
89. Yuki K, Astrof NS, Bracken C, Soriano SG, Shimaoka M: Sevoflurane binds and allosterically blocks integrin lymphocyte functionYassociated antigen-1. Anesthesiology 113:600-609, 2010.
90. Kurosawa S, Kato M: Anesthetics, immune cells, and immune responses. J Anesth 22:263-277, 2008.
91. Papadima A, Boutsikou M, Lagoudianakis EE, Kataki A, Konstadoulakis M, Georgiou L, Katergiannakis V, Manouras A: Lymphocyte apoptosis after major abdominal surgery is not influenced by anesthetic techniques: a comparative study of general anesthesia versus combined general and epidural analgesia. J Clin Anesth 21:414-421, 2009.
92. Matsuoka H, Kurosawa S, Horinouchi T, Kato M, Hashimoto Y: Inhalation anesthetics induce apoptosis in normal peripheral lymphocytes in vitro. Anesthesiology 95:1467-1472, 2002. (Pubitemid 33126760)
93. Loop T, Dovi-Akue D, Frick M, Roesslein M, Egger L, Humar M, Hoetzel A, Schmidt R, Borner C, Pahl HL, et al.: Volatile anesthetics induce caspasedependent, mitochondria-mediated apoptosis in human T lymphocytes in vitro. Anesthesiology 102:1147-1157, 2005. (Pubitemid 40745833)
94. Loop T, Scheiermann P, Doviakue D, Musshoff F, Humar M, Roesslein M, Hoetzel A, Schmidt R, Madea B, Geiger KK, et al.: Sevoflurane inhibits phorbol-myristate-acetateYinduced activator protein-1 activation in human T lymphocytes in vitro: potential role of the p38-stress kinase pathway. Anesthesiology 101:710-721, 2004. (Pubitemid 39121651)
95. Yu HP, Chaudry IH: The role of estrogen and receptor agonists in maintaining organ function after trauma-hemorrhage. Shock 31:227-237, 2009.
96. Du J, An J, Wei N, Guan T, Pritchard KA Jr, Shi Y: Increased resistance to LPS-induced myocardial dysfunction in the Brown Norway rats versus Dahl S rats: roles of inflammatory cytokines and nuclear factor kappaB pathway. Shock 33:332-336, 2010.
97. Roach JP, Moore EE, Partrick DA, Damle SS, Silliman CC, Mclntyre RC Jr, Banerjee A: Hemeoxygenase-1 induction in macrophages by a hemoglobinbased oxygen carrier reduces endotoxin-stimulated cytokine secretion. Shock 31:251-257, 2009.
98. Jan BU, Coyle SM, Macor MA, Reddell M, Calvano SE, Lowry SF: Relationship of basal heart rate variability to in vivo cytokine responses after endotoxin exposure. Shock 33:363-368, 2010.
99. Ozaki T, Habara K, Matsui K, Kaibori M, Kwon AH, Ito S, Nishizawa M, Okumura T: Dexamethasone inhibits the induction of iNOS gene expression through destabilization of its mRNA in proinflammatory cytokine-stimulated hepatocytes. Shock 33:64-69, 2010.
100. Yu HP, Hsieh PW, Chang YJ, Chung PJ, Kuo LM, Hwang TL: 2-(2-Fluorobenzamido)benzoate ethyl ester (EFB-1) inhibits superoxide production by human neutrophils and attenuates hemorrhagic shockYinduced organ dysfunction in rats. Free Radic Biol Med 50:1737-1748, 2011.
101. Yu HP, Hwang TL, Hsieh PW, Lau YT: Role of estrogen receptor-dependent upregulation of p38 MAPK/hemeoxygenase-1 in resveratrol-mediated attenuation of intestinal injury after trauma-hemorrhage. Shock 35:517-523, 2011.
102. Suda K, Takeuchi H, Hagiwara T, Miyasho T, Okamoto M, Kawasako K, Yamada S, Suganuma K, Wada N, Saikawa Y, et al.: Neutrophil elastase inhibitor improves survival of rats with clinically relevant sepsis. Shock 33: 526-531, 2011.
103. Yu HP, Hsieh PW, Chang YJ, Chung PJ, Kuo LM, Hwang TL: DSM-RX78, a new phosphodiesterase inhibitor, suppresses superoxide anion production in activated human neutrophils and attenuates hemorrhagic shockYinduced lung injury in rats. Biochem Pharmacol 78:983-992, 2009.
104. Olanders K, Sun Z, Borjesson A, Dib M, Andersson E, Lasson A, Ohlsson T, Andersson R: The effect of intestinal ischemia and reperfusion injury on ICAM-1 expression, endothelial barrier function, neutrophil tissue influx, and protease inhibitor levels in rats. Shock 18:86-92, 2002.
105. Paula-Neto HA, Alves-Filho JC, Souto FO, Spiller F, Amendola RS, Freitas A, Cunha FQ, Barja-Fidalgo C: Inhibition of guanylyl cyclase restores neutrophil migration and maintains bactericidal activity increasing survival in sepsis. Shock 35:17-27, 2011.
106. Alves-Filho JC, Spiller F, Cunha FQ: Neutrophil paralysis in sepsis. Shock 34(Suppl 1):15-21, 2010.
107. Liu FC, Liu FW, Yu HP: Ondansetron attenuates hepatic injury via p38 MAPK-dependent pathway in a rat haemorrhagic shock model. Resuscitation 82:335-340, 2011.
108. Yu HP, Yang SC, Lau YT, Hwang TL: Role of Akt-dependent up-regulation of hemeoxygenase-1 in resveratrol-mediated attenuation of hepatic injury after trauma-hemorrhage. Surgery 148:103-109, 2010.
109. Yu HP, Hsu JC, Hwang TL, Yen CH, Lau YT: Resveratrol attenuates hepatic injury after trauma-hemorrhage via estrogen receptorYrelated pathway. Shock 30:324-328, 2008.
110. Al-Mousawi AM, Kulp GA, Branski LK, Kraft R, Mecott GA, Williams FN, Herndon DN, Jeschke MG: Impact of anesthesia, analgesia, and euthanasia technique on the inflammatory cytokine profile in a rodent model of severe burn injury. Shock 34:261-268, 2010.
111. Yamaguchi K, Kawahara T, Kumakura S, Hua J, Kugimiya T, Nagaoka I, Inada E: Effect of olprinone, a phosphodiesterase III inhibitor, on hepatic ischemia-reperfusion injury in rats. Shock 33:436-441, 2010.
112. Vallabhaneni R, Kaczorowski DJ, Yaakovian MD, Rao J, Zuckerbraun BS: Heme oxygenase 1 protects against hepatic hypoxia and injury from hemorrhage via regulation of cellular respiration. Shock 33:274-281, 2010.
113. Lin YT, Chen YH, Yang YH, Jao HC, Abiko Y, Yokoyama K, Hsu C: Heme oxygenase-1 suppresses the infiltration of neutrophils in rat liver during sepsis through inactivation of p38MAPK. Shock 34:615-621, 2010.
114. Liu FC, Day YJ, Liao CH, Liou JT, Mao CC, Yu HP: Hemeoxygenase-1 upregulation is critical for sirtinol-mediated attenuation of lung injury after trauma-hemorrhage in a rodent model. Anesth Analg 108:1855-1861, 2009.
115. Lv X, Yang L, Tao K, Liu Y, Yang T, Chen G, Yu W, Lv H, Wu F: Isoflurane preconditioning at clinically relevant doses induce protective effects of hemeoxygenase-1 on hepatic ischemia reperfusion in rats. BMC Gastroenterol 11:31, 2011.
116. Frithiof R, Soehnlein O, Eriksson S, Fenhammar J, Hjelmqvist H, Lindbom L, Rundgren M: The effects of isoflurane anesthesia and mechanical ventilation on renal function during endotoxemia. Acta Anaesthesiol Scand 55:401-410, 2011.
117. Kong HY, Zhu SM, Wang LQ, He Y, Xie HY, Zheng SS: Sevoflurane protects against acute kidney injury in a small-size liver transplantation model. Am J Nephrol 32:347-355, 2010.
118. Cho EJ, Yoon JH, Hong SJ, Lee SH, Sim SB: The effects of sevoflurane on systemic and pulmonary inflammatory responses after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 23:639-645, 2009.
119. Kalb R, Schober P, Schwarte LA, Weimann J, Loer SA: Preconditioning, but not postconditioning, with sevoflurane reduces pulmonary neutrophil accumulation after lower body ischemia/reperfusion injury in rats. Eur J Anaesthesiol 25:454-459, 2008. (Pubitemid 351629962)
120. Taniuchi T, Yamamoto K, Ohmoto N, Ohta K, Kobayashi T: Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats. Crit Care Med 28:1101-1106, 2000. (Pubitemid 30262086)
121. Taniguchi T, Kanakura H, Yamamoto K: Effects of posttreatment with propofol on mortality and cytokine responses to endotoxin-induced shock in rats. Crit Care Med 30:904-907, 2002. (Pubitemid 34297816)
122. Chen HI, Hsieh NK, Kao SJ, Su CF: Protective effects of propofol on acute lung injury induced by oleic acid in conscious rats. Crit Care Med 36: 1214-1221, 2008. (Pubitemid 351482671)
123. Takaono M, Yogosawa T, Okawa-Takatsuji M, Aotsuka S: Effects of intravenous anesthetics on interleukin (IL)-6 and IL-10 production by lipopolysaccharide-stimulated mononuclear cells from healthy volunteers. Acta Anaesthesiol Scand 46:176-179, 2002. (Pubitemid 34250780)
124. Erol A, Reisli R, Reisli I, Kara R, Otelcioglu S: Effects of desflurane, sevoflurane and propofol on phagocytosis and respiratory burst activity of human polymorphonuclear leukocytes in bronchoalveolar lavage. Eur J Anaesthesiol 26:150-154, 2009.
125. Mikawa K, Akamatsu H, Nishina K, Shiga M, Maekawa N, Obara H, Niwa Y: Propofol inhibits human neutrophil functions. Anesth Analg 87:695-700, 1998. (Pubitemid 28397501)
126. Heine J, Jaeger K, Osthaus A, Weingaertner N, Munte S, Piepenbrock S, Leuwer M: Anaesthesia with propofol decreases FMLP-induced neutrophil respiratory burst but not phagocytosis compared with isoflurane. Br J Anaesth 85:424-430, 2000.
127. An K, Shu H, Huang W, Huang X, Xu M, Yang L, Xu K, Wang C: Effects of propofol on pulmonary inflammatory response and dysfunction induced by cardiopulmonary bypass. Anaesthesia 63:1187-1192, 2008.
128. Yu HP, Lui PW, Hwang TL, Yen CH, Lau YT: Propofol improves endothelial dysfunction and attenuates vascular superoxide production in septic rats. Crit Care Med 34:453-460, 2006.
129. Hsing CH, Lin MC, Choi PC, Huang WC, Kai JI, Tsai CC, Cheng YL, Hsieh CY, Wang CY, Chang YP, et al.: Anesthetic propofol reduces endotoxic inflammation by inhibiting reactive oxygen speciesYregulating Akt/IKKB"/NF-.B signaling. PLoS One 6:e17598, 2011.
130. Dikmen B, Yagmurdur H, Akgul T, Astarci M, Ustun H, Germiyanoglu C: Preventive effects of propofol and ketamine on renal injury in unilateral ureteral obstruction. J Anesth 24:73-80, 2010.
131. Wang L, Wu B, Sun Y, Xu T, Zhang X, Zhou M, Jiang W: Translocation of protein kinase C isoforms is involved in propofol-induced endothelial nitric oxide synthase activation. Br J Anaesth 104:606-612, 2010.
132. Wang B, Luo T, Chen D, Ansley DM: Propofol reduces apoptosis and upregulates endothelial nitric oxide synthase protein expression in hydrogen superoxideYstimulated human umbilical vein endothelial cells. Anesth Analg 105:1027-1033, 2007. (Pubitemid 47479317)
133. Vasileiou I, Kalimeris K, Nomikos T, XanthopoulouMN, Perrea D, Agrogiannis G, Nakos G, Kostopanagiotou G: Propofol prevents lung injury following intestinal ischemia-reperfusion. J Surg Res 2010 Aug 6 [Epub ahead of print].
134. Yuzbasioglu MF, Aykas A, Kurutas EB, Sahinkanat T: Protective effects of propofol against ischemia/reperfusion injury in rats kidneys. Ren Fail 32: 578-583, 2010.
135. Xia Z, Luo T, Liu HM, Wang F, Xia ZY, Irwin MG, Vanhoutte PM: LArginine enhances nitrative stress and exacerbates tumor necrosis factoralpha toxicity to human endothelial cells in culture: prevention by propofol. J Cardiovasc Pharmacol 55:358-367, 2010.
136. Chen J, Gu Y, Shao Z, Luo J, Tan Z: Propofol protects against hydrogen peroxideYinduced oxidative and cell dysfunction in human umbilical vein endothelial cells. Mol Cell Biochem 339:43-54, 2010.
137. Wang B, Shravah J, Luo H, Raedschelders K, Chen DD, Ansley DM: Propofol protects against hydrogen peroxideYinduced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation. Biochem Biophys Res Commun 389: 105-111, 2009.